Pharma groups spy opportunity in rare diseases
Worldwide sales of orphan drugs are forecast to total $262bn by 2026
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Rare Diseases